HIGH-DOSE CHEMOTHERAPY (HDCT) WITH AUTOLOGOUS BLOOD STEM-CELL (BPC) SUPPORT IN METASTATIC BREAST-CANCER (MBC)

被引:0
|
作者
GLUCK, S
NABHOLTZ, JM
CRUMP, M
HO, AD
机构
[1] NEORCC,SUDBURY,ON,CANADA
[2] CROSS CANC INST,EDMONTON,AB,CANADA
[3] TORONTO HOSP,TORONTO,ON,CANADA
[4] UNIV CALIF SAN DIEGO,SAN DIEGO,CA
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:754 / 754
页数:1
相关论文
共 50 条
  • [21] PROGNOSTIC FACTORS FOR PROLONGED PROGRESSION-FREE SURVIVAL WITH HIGH-DOSE CHEMOTHERAPY WITH AUTOLOGOUS STEM-CELL SUPPORT FOR ADVANCED BREAST-CANCER
    AYASH, LJ
    WHEELER, C
    FAIRCLOUGH, D
    SCHWARTZ, G
    REICH, E
    WARREN, D
    SCHNIPPER, L
    ANTMAN, K
    FREI, E
    ELIAS, A
    JOURNAL OF CLINICAL ONCOLOGY, 1995, 13 (08) : 2043 - 2049
  • [22] Stem cell dose and tumorbiologic parameters as prognostic markers for patients with metastatic breast cancer undergoing high-dose chemotherapy with autologous blood stem cell support
    Hensel, M
    Schneeweiss, A
    Sinn, HP
    Egerer, G
    Kornacker, M
    Solomayer, E
    Haas, R
    Bastert, G
    Ho, AD
    STEM CELLS, 2002, 20 (01) : 32 - 40
  • [23] HIGH-DOSE CYCLOPHOSPHAMIDE, THIOTEPA AND HYDROXYUREA WITH AUTOLOGOUS HEMATOPOIETIC STEM-CELL RESCUE - AN EFFECTIVE CONSOLIDATION CHEMOTHERAPY REGIMEN FOR EARLY METASTATIC BREAST-CANCER
    VAUGHAN, WP
    REED, EC
    EDWARDS, B
    KESSINGER, A
    BONE MARROW TRANSPLANTATION, 1994, 13 (05) : 619 - 624
  • [24] Combined treatment of metastatic breast cancer (MBC) by high-dose chemotherapy (HDCT) and bispecific antibodies: A pilot study
    Stemmler, HJ
    Salat, C
    Lindhofer, H
    Menzel, H
    Untch, M
    Kahlert, S
    Konecny, G
    Sauer, H
    Ledderose, G
    Heinemann, V
    Kolb, HJ
    ANTICANCER RESEARCH, 2005, 25 (04) : 3047 - 3054
  • [25] Preliminary results of high-dose chemotherapy (HDCT) with peripheral blood stem cell (PBSC) support in patients with breast cancer.
    Zmatchinski, V
    Uss, A
    Milanovich, N
    Skrahin, A
    Dzuba, E
    Mitskevich, O
    Zavgorodniay, I
    Batan, Z
    Vinogradov, V
    BONE MARROW TRANSPLANTATION, 1999, 23 : S193 - S193
  • [26] HIGH-DOSE CHEMOTHERAPY WITH AUTOLOGOUS PERIPHERAL STEM-CELL SUPPORT IN ADVANCED OVARIAN-CANCER
    BENEDETTIPANICI, P
    GREGGI, S
    SCAMBIA, G
    SALERNO, MG
    MENICHELLA, G
    PIERELLI, L
    FODDAI, ML
    BIZZI, B
    MANCUSO, S
    ANNALS OF MEDICINE, 1995, 27 (01) : 133 - 138
  • [27] High-Dose Chemotherapy With Autologous Hematopoietic Stem-Cell Transplantation in Metastatic Breast Cancer: Overview of Six Randomized Trials
    Berry, Donald A.
    Ueno, Naoto T.
    Johnson, Marcella M.
    Lei, Xiudong
    Caputo, Jean
    Smith, Dori A.
    Yancey, Linda J.
    Crump, Michael
    Stadtmauer, Edward A.
    Biron, Pierre
    Crown, John P.
    Schmid, Peter
    Lotz, Jean-Pierre
    Rosti, Giovanni
    Bregni, Marco
    Demirer, Taner
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (24) : 3224 - 3231
  • [28] HIGH-DOSE CHEMOTHERAPY FOR METASTATIC BREAST-CANCER
    LEONARD, RCF
    LANCET, 1994, 344 (8929): : 1084 - 1084
  • [29] Conventional-dose chemotherapy compared with high-dose chemotherapy plus autologous hematopoietic stem-cell transplantation for metastatic breast cancer.
    Stadtmauer, EA
    O'Neill, A
    Goldstein, LJ
    Crilley, PA
    Mangan, KF
    Ingle, JN
    Brodsky, I
    Martino, S
    Lazarus, HM
    Erban, JK
    Sickles, C
    Glick, JH
    NEW ENGLAND JOURNAL OF MEDICINE, 2000, 342 (15): : 1069 - 1076
  • [30] HIGH-DOSE MITOXANTRONE (M) FOR METASTATIC BREAST-CANCER (MBC)
    HOLMES, FA
    NEIDHART, JA
    HORTOBAGYI, GN
    ESPARZA, L
    BUZDAR, AU
    TASHIMA, C
    RO, JS
    BREAST CANCER RESEARCH AND TREATMENT, 1987, 10 (01) : 109 - 109